Select a Company
33.28 EGP +0.28 (+0.85%)
As of 01-Jun-2023
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products. In addition, it manufactures and distributes several other licensed products from other companies.
Glaxo Smith Kline
33.28 EGP +0.28 (+0.85%)As of 01-Jun-2023
| Sector Health Care |
Industry Pharmaceuticals & Biotechnology |
| Symbol BIOC |
ISIN EGS38171C012 |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products. In addition, it manufactures and distributes several other licensed products from other companies.
Website: www.gsk.com
|
EXCLUSIVE OFFER
Get FULL ACCESS to AFRICAN MARKETS for 10$
Subscribe today and get full access to detailled COMPANY PROFILES, LIBRARY and MARKET DATA:
1500+ listed companies (overview, interactive chart, market activity, shareholding, dividends, ...) 11000+ annual reports & financial statements (Unlimited PDF downloads) 17 Market indices Historical market data (Unlimited Excel Download)
You will enjoy all the exclusive features of African-markets.com including our Premium stories and research papers. Click here for a sample company profile.
|